These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 719133)

  • 1. Inhibition of CFU-S entry into cell cycle after irradiation and drug treatment.
    Guigon M; Frindel E
    Biomedicine; 1978 Jul; 29(5):176-8. PubMed ID: 719133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of various treatments of CFU-S seeding efficiency in mice.
    Dumenil D; Lauret E; Frindel E
    Exp Hematol; 1984 Oct; 12(9):749-52. PubMed ID: 6149146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-CFU-f: young-type stromal stem cells in murine bone marrow following administration of DNA inhibitors.
    Ben-Ishay Z; Prindull G; Sharon S; Borenstein A
    Int J Cell Cloning; 1986 Mar; 4(2):126-34. PubMed ID: 3958511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and characteristics of colony-forming units fibroblasts (CFU-F) in the bone marrow of weanling mice treated with cytosine arabinoside and phenylhydrazine: correlation with CFU-S, progenitors of diffusion-chamber colonies (CFU-D), and CFU-C.
    Ben-Ishay Z; Borenstein A; Sharon S; Prindull G
    Int J Cell Cloning; 1983 Oct; 1(5):343-59. PubMed ID: 6672102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral regulation of pluripotent stem cell differentiation.
    Frindel E
    Biomedicine; 1979 Jul; 31(4):113-7. PubMed ID: 486689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
    Paukovits WR; Paukovits JB; Moser MH; Konstantinov S; Schulte-Hermann R
    Exp Hematol; 1998 Aug; 26(9):851-8. PubMed ID: 9694506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of histamine at various concentrations on the cell cycle state of hematopoietic stem cells (CFU-s).
    Yi SN; Xu YH
    Int J Cell Cloning; 1988 Jul; 6(4):290-5. PubMed ID: 3418137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of 4-methylhistamine on the cell-cycle response between CFU-s and its subpopulation.
    Tang ZC; Xu YH
    Int J Cell Cloning; 1987 Nov; 5(6):511-7. PubMed ID: 3429935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioprotection of bone marrow stem cell subsets by interleukin-1 and kit-ligand: implications for CFU-S as the responsible target cell population.
    van Os R; Lamont C; Witsell A; Mauch PM
    Exp Hematol; 1997 Mar; 25(3):205-10. PubMed ID: 9091295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle status of murine megakaryocyte and granulocyte-macrophage colony-forming cells in bone marrow and spleen.
    Cen D; Levin J
    Exp Hematol; 1992 Oct; 20(9):1094-100. PubMed ID: 1468543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of high doses of cytosine arabinoside on pluripotent stem cells (CFU-S).
    Guigon M; Izumi-Hisha H; Mary JY
    Exp Hematol; 1989 Feb; 17(2):203-7. PubMed ID: 2912743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of the ability of stromal cell lines derived from different murine adult tissues to support maintenance of hematopoietic stem cells in vitro.
    Rios M; Williams DA
    J Cell Physiol; 1990 Dec; 145(3):434-43. PubMed ID: 1703166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of purified murine hemopoietic stem cells in serum-free cultures stimulated with purified stem-cell-activating factor.
    Migliaccio AR; Visser JW
    Exp Hematol; 1986 Dec; 14(11):1043-8. PubMed ID: 3536544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On control of the hematopoietic cell proliferation.
    Necas E; Sefc L; Znojil V
    Stem Cells; 1993 Jul; 11(4):319-25. PubMed ID: 8401255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of liquid culture and cell cycle analysis to compare drug damage following in vitro treatment of normal human bone marrow cells with adriamycin, arabinosyl-cytosine, and etoposide.
    Cavazzana M; Calvo F; Facchin P; Barreau P; Geny B; Dal Cortivo L; Dresch C
    Exp Hematol; 1988 Nov; 16(10):876-83. PubMed ID: 3169155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment.
    Wdzieczak-Bakala J; Guigon M; Lenfant M; Frindel E
    Biomed Pharmacother; 1983; 37(9-10):467-71. PubMed ID: 6689548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of bone marrow stromal cells (MSC) in mice after drug induced eradication of hematopoietic cells: in vitro effects on normal bone marrow.
    Ben-Ishay Z; Prindull G; Sharon S
    Biomed Pharmacother; 1982; 36(8-9):353-9. PubMed ID: 7182013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cells.
    Lopez M; Wdzieczak-Bakala J; Pradelles P; Frindel E
    Leukemia; 1991 Mar; 5(3):270-2. PubMed ID: 2013983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
    Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.